TARDBP and amyotrophic lateral sclerosis: Other metabolite profiling-based studies revealed significantly different metabolic profiles among FALS, SALS and ALS patients carrying different mutations in disease-causing genes (i.e., C9ORF72, SOD1, TARDBP, and FUS), suggesting the existence of distinct neurodegenerative processes associated with different subtypes of ALS (Wuolikainen et al., 2012; Jääskeläinen et al., 2019; Lanznaster et al., 2020).